Skip to content
Menu

GoodRx Holdings, Inc. GDRX

Full chart Compare
Set alert

Price alert · GDRX

All alert types
2.92 USD -0.10 (-3.31%)

Regular-session close

2.88 -0.04 -1.37%

After hours · Nov 20, 5:49 PM ET

2.91 Day range 3.09
1.87 52-week range 3.80
YTD
+7.75%
1 year
+11.45%

5D -0.59 (-16.81%)

33.203.403.60MonTueWedThuFri2.92
Market cap
996.14M
Revenue (ttm)
785.23M
Profit margin
2.07%
EPS (ttm)
0.05
Shares out
107.18M
P/E ratio
58.40
Forward P/E
8.58
YTD return
+7.75%
1-year return
+11.45%
50-day average
3.44
Volume
2.01M
Avg volume
1.09M
Open
2.98
Previous close
3.02
Day's range
2.91 – 3.09
52-week range
1.87 – 3.80
Beta
1.66
Analysts
Hold
Price target
3.95 (+35.3%)
Earnings date
Mar 4, 2027

Key statistics

200-day average
2.89
Enterprise value
1.39B
Price / sales
1.31
Price / book
1.59
Revenue growth
-1.30%
Free cash flow
112.50M
Total cash
296.11M
Total debt
538.95M
Return on equity
2.52%
Short % of float
3.73%

Fundamental scorecard

13 of 25 checks passed on GDRX’s reported financials

ValueGrowthProfitabilityHealthDividend

13of 25 checks passed

  • Value 3 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 4 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
GDRX Revenue — quarterly 200.41M
GDRX Net income — quarterly 8.54M
GDRX EPS — quarterly 0.03

Earnings

GDRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 4, 2027Dec 30, 20260.0773———
Nov 20, 2026Sep 30, 20260.0742———
Aug 5, 2026Jun 30, 20260.079680.080.00+0.40%
May 6, 2026Mar 31, 20260.070.070.000.00%
Feb 25, 2026Dec 31, 20250.090.090.000.00%
Nov 4, 2025Sep 30, 20250.090.08-0.01-11.11%

Upgrades / downgrades

GDRX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 21, 2026BarclaysmainUnderweightUnderweight
Aug 13, 2026UBSmainNeutralNeutral
Aug 11, 2026CitigroupmainBuyBuy
Aug 11, 2026TD CowenmainBuyBuy
Aug 7, 2026Wells FargomainOverweightOverweight
May 14, 2026CitigroupmainBuyBuy

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
goodrx.com

News

Your note

Sign in to keep a note on GDRX — it syncs with the Stock Master app.

Insider holders

GDRX insider holders
InsiderRelationLatest transactionDateShares held
BARNES WENDY LYNNChief Executive OfficerConversion of Exercise of derivative securityJul 14, 2026741,657
BEZDEK TREVORDirectorConversion of Exercise of derivative securityNov 1, 20265,644,230
BRUEHLMAN RONALD EDirectorConversion of Exercise of derivative securityNov 5, 2026229,044
HIRSCH DOUGLAS JOSEPHDirectorConversion of Exercise of derivative securityOct 25, 20265,606,900
KENNEDY KELLY JDirectorStock Award(Grant)Jun 15, 2026207,645
MCGINNIS CHRISTOPHER ALANChief Financial OfficerConversion of Exercise of derivative securityJul 14, 2026198,310

Institution ownership

GDRX institution ownership
Holder% heldSharesValueReported
Francisco Partners Management, LP50.21%52,578,184158.79MSep 29, 2026
LSV Asset Management5.60%5,868,89517.72MSep 29, 2026
Ameriprise Financial, Inc.4.90%5,127,23315.48MSep 29, 2026
Eversept Partners, LP4.79%5,019,60415.16MSep 29, 2026
Vanguard Capital Management LLC3.94%4,121,30712.45MSep 29, 2026
Silver Lake Group, LLC3.37%3,532,27610.67MSep 29, 2026

Fund ownership

GDRX fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.80%2,928,5408.84MJun 29, 2026
VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund1.21%1,264,0933.82MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.01%1,060,1223.20MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund0.97%1,019,7803.08MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund0.62%646,8561.95MJun 29, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio0.53%559,1641.69MJul 30, 2026